Unknown

Dataset Information

0

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.


ABSTRACT: The glomerular basement membrane (GBM) is a key component of the filtering unit in the kidney. Mutations involving any of the collagen IV genes (COL4A3, COL4A4, and COL4A5) affect GBM assembly and cause Alport syndrome, a progressive hereditary kidney disease with no definitive therapy. Previously, we have demonstrated that the bone morphogenetic protein (BMP) antagonist uterine sensitization-associated gene-1 (USAG-1) negatively regulates the renoprotective action of BMP-7 in a mouse model of tubular injury during acute renal failure. Here, we investigated the role of USAG-1 in renal function in Col4a3-/- mice, which model Alport syndrome. Ablation of Usag1 in Col4a3-/- mice led to substantial attenuation of disease progression, normalization of GBM ultrastructure, preservation of renal function, and extension of life span. Immunohistochemical analysis revealed that USAG-1 and BMP-7 colocalized in the macula densa in the distal tubules, lying in direct contact with glomerular mesangial cells. Furthermore, in cultured mesangial cells, BMP-7 attenuated and USAG-1 enhanced the expression of MMP-12, a protease that may contribute to GBM degradation. These data suggest that the pathogenetic role of USAG-1 in Col4a3-/- mice might involve crosstalk between kidney tubules and the glomerulus and that inhibition of USAG-1 may be a promising therapeutic approach for the treatment of Alport syndrome.

SUBMITTER: Tanaka M 

PROVIDER: S-EPMC2827946 | BioStudies | 2010-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC1464339 | BioStudies
2012-01-01 | S-EPMC3517557 | BioStudies
| S-EPMC6278936 | BioStudies
2016-01-01 | S-EPMC5154607 | BioStudies
2014-01-01 | S-EPMC4182137 | BioStudies
2014-01-01 | S-EPMC4245465 | BioStudies
2020-01-01 | S-EPMC7073208 | BioStudies
2018-01-01 | S-EPMC6767408 | BioStudies
2019-01-01 | S-EPMC6779358 | BioStudies
2003-01-01 | S-EPMC1868284 | BioStudies